The role of vigabatrin in childhood seizure disorders: Results from a clinical audit

Epilepsia

Volumn 42, Issue 1, 2001, Pages 54-61

  Prasad, Asuri N ^a,c   Penney, S ^b   Buckley, David J ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b New Janeway Childrens Health and Rehabilitation Centre   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Infantile spasms; Partial seizures; Refractory epilepsy; Tuberous sclerosis; Vigabatrin; Visual field loss

Indexed keywords

VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; EPILEPTOGENESIS; FEMALE; GENERALIZED EPILEPSY; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERIMETRY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADOLESCENT; ADULT; AGE FACTORS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; INFANT; MALE; MEDICAL AUDIT; PERIMETRY; PREVALENCE; RETROSPECTIVE STUDIES; SPASMS, INFANTILE; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; VIGABATRIN; VISION DISORDERS; VISUAL FIELDS;

EID: 0035116501     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.23100.x     Document Type: Article

References (37)

1. Vigabatrin
2. Vigabatrin in childhood epilepsy
3. Vigabatrin in childhood epilepsy: Comparable efficacy for generalized and partial seizures
4. Vigabatrin in the treatment of childhood epilepsies: A single-blind placebo-controlled study
5. The neuropathology of vigabatrin
6. A study of the effects of vigabatrin on the central nervous system and retina of Sprague-Dawley and Lister Hooded rats
7. Neuropathologic findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy
8. MRI findings in epileptic patients on vigabatrin for more than 5 years
9. Severe persistent visual field constriction associated with vigabatrin
10. Severe persistent visual field constriction associated with vigabatrin: Reaction might be dose dependent
11. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin
12. Vigabatrin-associated retinal cone system dysfunction: Electroretinogram and ophthalmologic findings
13. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain
14. Effect of chronic vigabatrin administration on the immature rat brain
15. Is the devil we know the lesser of two evils? Vigabatrin and visual fields
16. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy
17. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain
18. GABA changes with vigabatrin in the developing human brain
19. ACTH versus vigabatrin therapy in infantile spasms: A retrospective study
20. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes
21. Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study
22. Treatment of pediatric epilepsies with gamma-vinyl GABA (vigabatrin)
23. Therapeutic trial of vigabatrin in refractory infantile spasms
24. Vigabatrin in refractory childhood epilepsy: The Brazilian Multicenter Study
25. Vigabatrin in intractable childhood epilepsy: A retrospective study
26. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis
27. Vigabatrin as initial therapy for infantile spasms: A European retrospective survey: Sabril IS Investigator and Peer Review Groups
28. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: Literature review
29. Visual field constriction in children treated with vigabatrin
30. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
31. Visual function loss from vigabatrin: Effect of stopping the drug
32. Vigabatrin and the developing brain
33. Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intramyelinic edema in canine brain
34. Vigabatrin (gamma-vinyl-GABA): Neuropathologic evaluation in five patients
35. The potential for vigabatrin-induced intramyelinic edema in humans
36. Separating the retinal electrophysiologic effects of vigabatrin: Treatment versus field loss
37. Using the electroretinogram to detect and monitor the retinal toxicity of anticonvulsants